Search Results - "MCKENDRICK, Joe"

Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen by VAN CUTSEM, Eric, TABERNERO, Josep, MCKENDRICK, Joe, POLIKOFF, Jonathan, TELLIER, Alexia, CASTAN, Rémi, ALLEGRA, Carmen, LAKOMY, Radek, PRENEN, Hans, PRAUSOVA, Jana, MACARULLA, Teresa, RUFF, Paul, HAZEL, Guy A. Van, MOISEYENKO, Vladimir, FERRY, David

“…Treatment for metastatic colorectal cancer (mCRC) commonly involves a fluoropyrimidine-based chemotherapy regimen such as infusional fluorouracil, leucovorin,…”
Get full text

Impact of primary tumor site on bevacizumab efficacy in metastatic colorectal cancer by Wong, Hui-li, Lee, Belinda, Field, Kathryn, Lomax, Anna, Tacey, Mark, Shapiro, Jeremy, McKendrick, Joe, Zimet, Allan, Yip, Desmond, Nott, Louise, Jennens, Ross, Richardson, Gary, Tie, Jeanne, Kosmider, Suzanne, Parente, Phillip, Lim, Lionel, Cooray, Prasad, Tran, Ben, Desai, Jayesh, Wong, Rachel, Gibbs, Peter

“…Abstract Background With an ever-increasing focus on personalized medicine, all factors known to affect treatment response need to be considered when defining…”
Get full text

Oral Capecitabine Compared With Intravenous Fluorouracil Plus Leucovorin in Patients With Metastatic Colorectal Cancer: Results of a Large Phase III Study by VAN CUTSEM, Eric, TWELVES, Chris, MCKENDRICK, Joe, OSTERWALDER, Bruno, PEREZ-MANGA, Gumersindo, ROSSO, Riccardo, ROUGIER, Philippe, SCHMIEGEL, Wolff H, SEITZ, Jean-Francois, THOMPSON, Paul, VIEITEZ, Jose Maria, HARPER, Peter, CASSIDY, Jim, WEITZEL, Christof, ALLMAN, David, BAJETTA, Emilio, BOYER, Michael, BUGAT, Roland, FINDLAY, Mike, FRINGS, Stefan, JAHN, Michaela

“…To compare the efficacy and safety of orally administered capecitabine (Xeloda; Roche Laboratories, Inc, Nutley, NJ), a novel fluoropyrimidine carbamate…”
Get full text

Metastatic urachal cancer responding to FOLFOX chemotherapy by Tran, Ben, McKendrick, Joe

“…Metastatic urachal cancer is a rare disease and subsequently, does not have a defined systemic treatment. Although urachal cancer is most commonly…”
Get more information

Hodgkin lymphoma: an Australian experience of ABVD chemotherapy in the modern era by Jalali, Azim, Ha, Francis J., Chong, Geoff, Grigg, Andrew, Mckendrick, Joe, Schwarer, Anthony P., Doig, Rowan, Hamid, Anis, Hawkes, Eliza A.

“…Approximately 560 new cases of Hodgkin lymphoma (HL) are diagnosed annually in Australia. Standard first-line therapy is ABVD (doxorubicin, bleomycin,…”
Get full text

Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab by Roohullah, Aflah, Wong, Hui-Li, Sjoquist, Katrin M, Gibbs, Peter, Field, Kathryn, Tran, Ben, Shapiro, Jeremy, Mckendrick, Joe, Yip, Desmond, Nott, Louise, Gebski, Val, Ng, Weng, Chua, Wei, Price, Timothy, Tebbutt, Niall, Chantrill, Lorraine

“…To investigate the safety and efficacy of adding bevacizumab to first-line chemotherapy in metastatic colorectal cancer patients with peritoneal disease. We…”
Get full text

Evaluation of the Effect of Aflibercept (Z) on Os by Timing of 1st Line Disease Progression: A Post-Hoc Analysis of the Velour Trial by Edith, Mitchell, Guy, van Hazel, David, Cunningham, Dirk, Arnold, Hans-Joachim, Schmoll, Albert, ten Tije, Joe, Mckendrick, Florence, Joulain, Michael, Andria, Raghu, Vishwanath, Paulo, Hoff

Get full text

A multicenter, randomized, open-label study to assess the steady-state pharmacokinetics of bevacizumab given with either XELOX or FOLFOX-4 in patients with metastatic colorectal cancer by Zhi, Jianguo, Chen, Eric, Major, Pierre, Burns, Ivon, Robinson, Bridget, McKendrick, Joe, Rittweger, Karen, Abt, Markus, Goldstein, David

“…Purpose To compare the pharmacokinetics (PK) of bevacizumab (BV) at steady-state under two different dosing regimens, 7.5 mg/kg q3w and 5.0 mg/kg q2w,…”
Get full text

Late relapse of metastatic testicular nonseminomatous germ cell cancer: surgery is needed for cure by GELDART, THOMAS R., GALE, JOANNA, McKENDRICK, JOE, KIRBY, JULIE, MEAD, GRAHAM

“…OBJECTIVE To identify patients with late relapse of metastatic, nonseminomatous germ cell tumour (NSGCT) and to evaluate the patterns of relapse, treatment and…”
Get full text

Multicenter phase 2 trial of thalidomide in relapsed/refractory multiple myeloma: adverse prognostic impact of advanced age by Mileshkin, Linda, Biagi, James J., Mitchell, Paul, Underhill, Craig, Grigg, Andrew, Bell, Richard, McKendrick, Joe, Briggs, Peter, Seymour, John F., Lillie, Kate, Smith, Jennifer G., Zeldis, Jerome B., Prince, H. Miles

“…Relapsed or refractory multiple myeloma has a poor outlook. Some patients respond to thalidomide; however, criteria for predicting response have not been…”
Get full text

Capecitabine: A Viewpoint by Joe McKendrick by McKendrick, Joe

Get full text

Single dose rasburicase in tumor lysis: One hospital's experience by STEEL, Simone, COUTSOUVELIS, John, MCKENDRICK, Joe

“…Background:  Tumor lysis syndrome is an oncological emergency occurring mainly in high‐grade hematological malignancies. It results in significant biochemical…”
Get full text

Tolerability of accelerated chest irradiation and impact on survival of prophylactic cranial irradiation in patients with limited-stage small cell lung cancer: review of a single institution's experience by Ng, Michael, Chong, Jennifer, Milner, Alvin, MacManus, Michael, Wheeler, Greg, Wirth, Andrew, Michael, Michael, Ganju, Vinod, McKendrick, Joe, Ball, David

“…Evidence that has been published in the last decade indicates that in patients with limited-stage small-cell lung cancer (SCLC), hyperfractionated accelerated…”
Get more information

Liver metastases in germ cell cancer: defining a role for surgery after chemotherapy by Copson, Ellen, McKendrick, Joe, Hennessey, Niklas, Tung, Ken, Mead, Graham Z.

“…OBJECTIVE To review the clinical course and outcome of patients with germ cell cancer and liver metastases treated at one centre, as the presence of hepatic…”
Get full text

Peripheral Blood Stem Cell (PBSC) Mobilization in Patients with Multiple Myeloma: Low Dose Versus Intermediate Dose Cyclophosphamide by Hiwase, Devendra K., Schwarer, Anthony P., Mckendrick, Joe J., Bollard, Geraldine M., Hiwase, Smita D., Michael, Bailey M.

“…Aim: Autologous peripheral blood stem cell transplant (PBSCT) is standard of care for multiple myeloma patients younger than 65 years of age. However there is…”
Get full text

P-603 Symptom response following high dose (HD) palliative radiotherapy (RT) plus concurrent weekly vinorelbine (V) and cis-platinum (C) in patients with locally advanced and metastatic non-small cell lung cancer (NSCLC): Results of a phase-I study by Wirth, Andrew, Michael, Michael, Ball, David, MacManus, Michael, Rischin, Danny, Solomon, Ben, D'Costa, Ieta, McKendrick, Joe, Smith, Jenny, Mukesh, Bickol

Get full text

'Reuse' as a Value Driver for SOA by McKendrick, Joe

Get full text

Nonseminomatous germ cell tumor with very high serum human chorionic gonadotropin by McKendrick, J J, Theaker, J, Mead, G M

“…Most patients with disseminated nonseminomatous germ cell tumor (NSGCT) have an excellent prognosis with modern chemotherapy, although certain subgroups with a…”
Get more information

Lean body mass, body surface area and epirubicin kinetics by Cosolo, W C, Morgan, D J, Seeman, E, Zimet, A S, McKendrick, J J, Zalcberg, J R

“…For a number of cytotoxics, a relationship between efficacy and plasma concentrations has recently been demonstrated. Lean body mass has been demonstrated to…”
Get more information